Skip to main content
OUTCOME
2.3
Access to health technologies, innovation, and production
Resilient health systems and services based on primary health care
PB
2026-2027
Access to health technologies, innovation, and production
2.3. Increased access for all to and rational use of quality, affordable, and effective medicines, vaccines, diagnostics and other health technologies and services, strengthening innovation and production, generating ecosystems, and addressing access barriers across the full life cycle of health technologies
Budget
Approved Budget PB (Previous)
41.5
US$ MILLION
Priority

Low

Proposed Budget PB (Current)
39.3
US$ MILLION
Related Outputs and Indicators
  • 2.3.1.a Number of countries and territories provided with technical cooperation to develop policies and/or strategies for timely access to affordable health technologies for all
    Baseline
    3
    Target
    12
  • 2.3.1.b Number of countries and territories that have policies and/or strategies for timely access to affordable health technologies for all
    Baseline
    9
    Target
    12
  • 2.3.2.a Number of countries and territories provided with technical cooperation to develop and/or implement Institutional Development Plans (IDP) to strengthen regulatory capacities
    Baseline
    2
    Target
    20
  • 2.3.2.b Number of countries and territories that have established an IDP to improve regulatory capacity for health technologies based on the assessment of their national regulatory capacities by the internationally recognized Global Benchmarking Tool
    Baseline
    3
    Target
    18
  • 2.3.3.a Number of countries and territories provided with technical cooperation to develop and implement policies, strategies, and/or programs for innovation and production of health technologies
    Baseline
    0
    Target
    6
  • 2.3.3.b Number of countries and territories implementing policies, strategies, and/or programs for innovation and production of health technologies
    Baseline
    4
    Target
    7
  • 2.3.4.a Number of countries and territories provided with technical cooperation to increase access to pharmaceutical, blood, transplant, and radiological services, and strengthen radiation safety
    Baseline
    1
    Target
    3
  • 2.3.4.b Number of countries and territories implementing a plan to increase access to pharmaceutical, blood, transplant, and radiological services, and strengthen radiation safety
    Baseline
    2
    Target
    6
  • 2.3.5.a Number of countries and territories provided with technical cooperation to develop and enhance institutional frameworks and/or strategies for health technology assessment, incorporation, and/or management
    Baseline
    2
    Target
    12
  • 2.3.5.b Number of countries and territories implementing institutional frameworks and/or strategies for health technology assessment, incorporation, and/or management
    Baseline
    4
    Target
    8
  • 2.3.6 a Number of countries and territories provided with technical cooperation to develop strategies and/or mechanisms for improving rational use of health technologies, such as antimicrobial stewardship

    Baseline
    7
    Target
    7
  • 2.3.6.b Number of countries and territories that implement strategies and/or mechanisms for improving the rational use of health technologies, such as antimicrobial stewardship
    Baseline
    3
    Target
    3
  • 2.3.7.a Number of product items with established terms and conditions that are available to Member States through the Regional Revolving Funds
    Baseline
    398 (Baseline 2024)
    Target
    420
  • 2.3.7.b Number of regionally pre defined health programs in countries and territories that have procured health technologies through the Regional Revolving Funds
    Baseline
    105/420 (Baseline 2024)
    Target
    115/420
Key Interventions

    • Provide guidance and technical cooperation to support the development and implementation of updated policies, norms, and strategies that ensure timely access to and rational use of affordable, quality-assured, and cost-effective health technologies, including but not limited to pharmaceuticals, vaccines, diagnostics, and medical devices. 

    • Provide technical cooperation to strengthen country capacities to manage and oversee health technologies supply chains at all levels, including down to health facilities, and promote and facilitate the use of regional procurement mechanisms to better leverage demand and increase access to safe and affordable health technologies.  

    • Provide technical cooperation to ensure access to pharmaceutical, blood, transplant, and radiological services, and to strengthen radiation safety  

    • Foster intersectoral and interdepartmental cooperation and regional networks and other collaborative mechanisms to strengthen capacities, information sharing, and partnerships to improve governance and oversight by national health and regulatory authorities regarding the assessment, selection, incorporation, regulation, and use of health technologies.  

    • Provide technical cooperation to strengthen regional capacities for innovation and production of health technologies, promoting the development of enabling ecosystems and fostering strategic initiatives to increase access.